These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome. Strayer DR; Carter WA; Brodsky I; Cheney P; Peterson D; Salvato P; Thompson C; Loveless M; Shapiro DE; Elsasser W Clin Infect Dis; 1994 Jan; 18 Suppl 1():S88-95. PubMed ID: 8148460 [TBL] [Abstract][Full Text] [Related]
10. Immunological and psychological dysfunction in patients receiving immunotherapy for chronic fatigue syndrome. Hickie I; Lloyd A; Wakefield D Aust N Z J Psychiatry; 1992 Jun; 26(2):249-56. PubMed ID: 1642616 [TBL] [Abstract][Full Text] [Related]
12. Use of lisdexamfetamine dimesylate in treatment of executive functioning deficits and chronic fatigue syndrome: a double blind, placebo-controlled study. Young JL Psychiatry Res; 2013 May; 207(1-2):127-33. PubMed ID: 23062791 [TBL] [Abstract][Full Text] [Related]
13. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Vercoulen JH; Swanink CM; Zitman FG; Vreden SG; Hoofs MP; Fennis JF; Galama JM; van der Meer JW; Bleijenberg G Lancet; 1996 Mar; 347(9005):858-61. PubMed ID: 8622391 [TBL] [Abstract][Full Text] [Related]
14. Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome. Montoya JG; Kogelnik AM; Bhangoo M; Lunn MR; Flamand L; Merrihew LE; Watt T; Kubo JT; Paik J; Desai M J Med Virol; 2013 Dec; 85(12):2101-9. PubMed ID: 23959519 [TBL] [Abstract][Full Text] [Related]
15. A placebo-controlled, double-blind, randomized controlled trial of a natural killer cell stimulant (BioBran MGN-3) in chronic fatigue syndrome. McDermott C; Richards SC; Thomas PW; Montgomery J; Lewith G QJM; 2006 Jul; 99(7):461-8. PubMed ID: 16809351 [TBL] [Abstract][Full Text] [Related]
17. Effect of coenzyme Q10 plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome - A randomized, controlled, double-blind trial. Castro-Marrero J; Sáez-Francàs N; Segundo MJ; Calvo N; Faro M; Aliste L; Fernández de Sevilla T; Alegre J Clin Nutr; 2016 Aug; 35(4):826-34. PubMed ID: 26212172 [TBL] [Abstract][Full Text] [Related]
18. Effect of galantamine hydrobromide in chronic fatigue syndrome: a randomized controlled trial. Blacker CV; Greenwood DT; Wesnes KA; Wilson R; Woodward C; Howe I; Ali T JAMA; 2004 Sep; 292(10):1195-204. PubMed ID: 15353532 [TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial. Fazekas F; Lublin FD; Li D; Freedman MS; Hartung HP; Rieckmann P; Sørensen PS; Maas-Enriquez M; Sommerauer B; Hanna K; ; Neurology; 2008 Jul; 71(4):265-71. PubMed ID: 18645164 [TBL] [Abstract][Full Text] [Related]
20. Combination therapy with hydrocortisone and fludrocortisone does not improve symptoms in chronic fatigue syndrome: a randomized, placebo-controlled, double-blind, crossover study. Blockmans D; Persoons P; Van Houdenhove B; Lejeune M; Bobbaers H Am J Med; 2003 Jun; 114(9):736-41. PubMed ID: 12829200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]